Lansoprazole-associated lymphocytic colitis;Colite lymphocytaire associee a la prise de lansoprazole

Gastroenterologie Clinique et Biologique

Volumn 24, Issue 10, 2000, Pages 960-962

  Ghilain, Jean Michel ^a   Schapira, Michaël ^a   Maisin, Jean Marc ^a   De Maeght, Stéphane ^a   Piron, Anne ^a   Gerard, Raymonde ^a   Henrion, Jean ^a  

^a Hospital de Jolimont   (Belgium)

Author keywords

Drug induced colitis; Lansoprazole; Lymphocytic colitis; Microscopic colitis

Indexed keywords

LANSOPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIULCER AGENT; DRUG DERIVATIVE; OMEPRAZOLE;

ADULT; ARTICLE; CASE REPORT; COLITIS; DIARRHEA; FEMALE; HUMAN; INCIDENCE; MALABSORPTION; REMISSION; CHEMICALLY INDUCED DISORDER; INTESTINE MUCOSA; LYMPHOCYTE; MALE; MIDDLE AGED; PATHOLOGY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; COLITIS; DIARRHEA; HUMANS; INTESTINAL MUCOSA; LYMPHOCYTES; MALE; MIDDLE AGED; OMEPRAZOLE;

EID: 0034294591     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lymphocytic colitis: A distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis
2. Lymphocytic colitis: Clinical presentation and long term course
3. Les colites microscopiques
4. Drug induced lymphocytic colitis
5. Ranitidine, diarrhoea and lymphocytic colitis
6. Lymphocytic ('microscopic') colitis: A comparative histopathological study with particular reference to collagenous colitis
7. Lansoprazole associated microscopic colitis
8. Small intestine in lymphocytic and collagenous colitis: Mucosal morphology, permeability, and secretory immunity to gliadin
9. Colorectal ulcers associated with sodium phosphate catharsis
10. Colorectal inflammation and increased cell proliferation with oral sodium phosphate bowel preparation solution
11. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole
12. Severe nontyphoidal salmonellosis probably in relation with omeprazole treatment: Report of 2 cases
13. Safety profile of Lansoprazole: The US clinical trial experience
14. Safety of lansoprazole
15. A prospective follow-up study of 5669 users of lansoprazole in daily practice
16. Lansoprazole associated diarrhea. An emerging problem
17. Lansoprazole: A cause of secretory diarrhea